A Heterotrinuclear Ir(III)–Gd(III) Complex as a Mito‐Bomb for Bimodal Imaging–Guided Precision Cancer Therapy
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202501884 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Jiaxi Ru und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute For Advanced Research, Cixi Biomedical Research Institute, Wenzhou Medical University, Zhejiang, 325000, P. R. China. Hauptthemen laut MEDLINE: Iridium, Gadolinium, Mitochondria, Coordination Complexes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ningbo Natural Science Foundation, Wenzhou Medical University.
Abstract (Originalsprache)
Multimodal imaging–guided precision therapy has emerged as a cutting‐edge theranostic strategy that integrates real‐time diagnostic feedback with precision therapeutic intervention in a single platform, significantly enhancing treatment efficacy and minimizing off‐target effects. Herein, Ir(III)–Gd(III) heterometallic complexes ( Ir 2 Gd 1 ) that exhibit exceptional mitochondrial targeting capabilities and magneto‐optical bifunctional properties are designed and synthesized. As a single‐molecule theranostic agent, Ir 2 Gd 1 serves as a magnetic resonance imaging (MRI) contrast agent with high relaxivity (9.42 mM −1 s −1 ), while its intrinsic phosphorescence facilitates both optical imaging and phototherapy. Notably, Ir 2 Gd 1 can selectively accumulate within cancer cell mitochondria. Upon light irradiation, it generates singlet oxygen, which disrupts mitochondrial integrity by inducing cytochrome c release, thereby activating apoptosis or pyroptosis pathways. Additionally, Ir 2 Gd 1 photocatalytically oxidizes NADH, disrupting the mitochondrial electron transport chain and depleting ATP, further impairing cellular energy metabolism. Mechanistic investigations further reveal that Ir 2 Gd 1 activates the caspase‐3/GSDME signaling axis to induce pyroptosis, a mechanism crucial for overcoming apoptosis resistance and triggering anti‐tumor immune responses. Collectively, Ir 2 Gd 1 functions as a “Mito‐Bomb” that targets cancer cells' central powerhouse, executing focused detonation to achieve potent antitumor efficacy. This study presents a novel single‐molecule theranostic tool for tumor phototherapy and pyroptosis guided by magneto‐optical dual‐modal imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute For Advanced Research, Cixi Biomedical Research Institute, Wenzhou Medical University, Zhejiang, 325000, P. R. China.
- MOE Frontiers Science Center for Rare Isotopes, Key Laboratory of Nonferrous Metal Chemistry and Resources Utilization of Gansu Province, Engineering Research Center of Rare Earth Functional Materials, Ministry of Educa…
ORCID-Profile: Jiaxi Ru
Förderung
- National Natural Science Foundation of China
- Ningbo Natural Science Foundation
- Wenzhou Medical University
- Fundamental Research Funds for the Central Universities
- Natural Science Foundation of Ningbo Municipality
Zitieren
APA
Ru, J., Chen, Y., Tao, S., Xu, K., Liang, C., Kou, M., Tang, X., & Liu, W. (2026). A Heterotrinuclear Ir(III)–Gd(III) Complex as a Mito‐Bomb for Bimodal Imaging–Guided Precision Cancer Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202501884
Vancouver
Ru J, Chen Y, Tao S, Xu K, Liang C, Kou M, et al. A Heterotrinuclear Ir(III)–Gd(III) Complex as a Mito‐Bomb for Bimodal Imaging–Guided Precision Cancer Therapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202501884
BibTeX
@article{Ru2026,
author = {Ru, Jiaxi and Chen, Yu and Tao, Siyi and Xu, Kuang and Liang, Chao and Kou, Manchang and Tang, Xiaoliang and Liu, Weisheng},
title = {A Heterotrinuclear Ir(III)–Gd(III) Complex as a Mito‐Bomb for Bimodal Imaging–Guided Precision Cancer Therapy},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202501884}
}
EUVIMED